Canaccord Genuity Maintains a 'Hold' on AspenBio Pharma (APPY); Update with Management

January 14, 2011 11:15 AM EST Send to a Friend
Canaccord Genuity maintains a 'Hold' on AspenBio Pharma (NASDAQ: APPY), $0.50 price target.

Canaccord analyst says, "While we believe AspenBio ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login